首页> 外国专利> POLYPEPTIDES HAVING A .BETA.-ADREMERGIC RECEPTOR ACTIVITY IN HUMANS, INVOLVED_IN THE LIPOLYTIC RESPONSE, NUCLEIC ACIDS CODING FOR THESE POLYPEPTIDES AND USE OF THESE POLYPEPTIDES FOR THE SCREENING OF ACTIVE SUBSTANCES ON THESE POLYPEPTIDES

POLYPEPTIDES HAVING A .BETA.-ADREMERGIC RECEPTOR ACTIVITY IN HUMANS, INVOLVED_IN THE LIPOLYTIC RESPONSE, NUCLEIC ACIDS CODING FOR THESE POLYPEPTIDES AND USE OF THESE POLYPEPTIDES FOR THE SCREENING OF ACTIVE SUBSTANCES ON THESE POLYPEPTIDES

机译:具有人类β-淀粉样受体活性的多肽,参与脂解性反应,这些多肽的核酸编码,以及使用这些多肽筛选这些多肽上的活性物质

摘要

PCT No. PCT/FR90/00054 Sec. 371 Date Sep. 3, 1991 Sec. 102(e) Date Sep. 3, 1991 PCT Filed Jan. 25, 1990 PCT Pub. No. WO90/08775 PCT Pub. Date Aug. 9, 1990.Novel polypeptides having a (beta)-adrenergic receptor activity containing the sequence of 402 amino acids, or a fragment of this sequence, said fragment being such that, in particular, either it nonetheless includes the sites contained in said sequence and whose presence is necessary so that, when the fragment is exposed to the surface of a cell, it is capable of participating in the activation of the cyclase adenylate in the presence of an agonist, or it is likely to be recognized by antibodies which also recognize the above succession of 402 amino acids, but fail to recognize the (beta)1 adrenergic receptor and the (beta)2 adrenergic receptor. These polypeptides are useful for screening drugs which act on said polypeptides and for treating obesity, fat diabetes and hyperlipidemias.
机译:PCT号PCT / FR90 / 00054第二部分371日期1991年9月3日秒102(e)1991年9月3日,PCT申请,1990年1月25日提交,PCT公开。 WO90 / 08775 PCT公开号1990年8月9日,具有β-肾上腺素能受体活性的新颖多肽,其包含402个氨基酸的序列,或该序列的片段,所述片段使得特别是无论如何仍包含包含在其中的位点。所述序列及其存在的必要条件,以便在片段暴露于细胞表面时能够在激动剂存在的情况下参与环化酶腺苷酸的活化,或者很可能被抗体识别它们也能识别上述的402个氨基酸序列,但不能识别β1肾上腺素能受体和β2肾上腺素能受体。这些多肽可用于筛选作用于所述多肽的药物,并用于治疗肥胖症,脂肪糖尿病和高脂血症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号